Chemed (CHE) vs Hims & Hers Health (HIMS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Chemed (CHE) has outperformed Hims & Hers Health (HIMS) over the past year, gaining 15.0% versus a loss of 49.0%. Over five years, HIMS leads with a +253.3% price change compared with +16.6% for CHE. Hims & Hers Health is the larger company by market cap ($6.89 billion vs $6.55 billion), about 1.1 times the size.
On valuation, Chemed trades at a lower forward P/E (18.2x vs 40.1x for Hims & Hers Health). Chemed pays a dividend yielding 0.48%, while Hims & Hers Health does not currently pay one. Chemed converts more of its revenue into profit, with a net margin of 10.5% versus 5.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CHE | HIMS |
|---|---|---|
| Share price | $501.45 | $29.54 |
| Market cap | $6.55B | $6.89B |
| 1-day change | -1.65% | +0.24% |
| YTD return | +17.20% | -9.02% |
| 1-year return | +14.99% | -49.04% |
| 5-year return | +16.58% | +253.35% |
| P/E ratio (TTM) | 25.22 | — |
| Forward P/E | 18.22 | 40.07 |
| EPS (TTM) | $19.88 | $-0.64 |
| Dividend yield | 0.48% | 0.00% |
| Annual dividend | $2.40 | $0.00 |
| Revenue (latest FY) | $2.53B | $2.35B |
| Revenue growth (YoY) | +4.06% | +59.00% |
| Net income (latest FY) | $265.24M | $128.37M |
| Gross margin | 32.54% | 73.84% |
| Operating margin | 13.37% | 4.50% |
| Net margin | 10.48% | 5.47% |
| 52-week high | $557.00 | $65.30 |
| 52-week low | $365.21 | $13.74 |
| Distance from 52-week high | -9.97% | -54.76% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +13.99% | +5.45% |
| Average volume | 160.10K | 12.07M |
| Shares outstanding | 13.07M | 224.94M |
| Employees | 15,811 | 2,442 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CHE has outperformed HIMS by 64.0 percentage points over the past year.
- Chemed is more profitable, keeping 10.5 cents of every revenue dollar as net income versus 5.5 cents for Hims & Hers Health.
- Hims & Hers Health grew revenue faster in its latest fiscal year (+59.00% vs +4.06%).
About Chemed
CHE stock →Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments.
Health Care · Medical/Nursing Services · 15,811 employees
About Hims & Hers Health
HIMS stock →Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally.
Health Care · Medical/Nursing Services · 2,442 employees
CHE vs HIMS FAQ
Which is bigger, Chemed or Hims & Hers Health?
Hims & Hers Health (HIMS) is larger, with a market capitalization of $6.89B compared with $6.55B for Chemed (CHE).
Which stock has performed better over the past year, CHE or HIMS?
CHE returned +14.99% over the past 12 months, compared with -49.04% for HIMS (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Chemed or Hims & Hers Health?
Chemed pays a dividend yielding 0.48%, while Hims & Hers Health does not currently pay a regular dividend.
Are Chemed and Hims & Hers Health in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.